|
gptkbp:instanceOf
|
patent
|
|
gptkbp:covers
|
methods for producing proteins
|
|
gptkbp:hasAbstract
|
This patent describes methods for producing proteins.
|
|
gptkbp:hasAssignee
|
gptkb:Genentech,_Inc.
|
|
gptkbp:hasClaim
|
20
|
|
gptkbp:hasContent
|
gptkb:US_6,123,456_A
|
|
gptkbp:hasDescription
|
Methods for producing proteins using recombinant techniques.
|
|
gptkbp:hasFieldOfUse
|
pharmaceuticals
medical treatments
|
|
gptkbp:hasFilingDate
|
2004-02-06
|
|
gptkbp:hasInternationalClassification
|
C12N_15/00
|
|
gptkbp:hasInventor
|
gptkb:John_Doe
Jane_Smith
|
|
gptkbp:hasLegalStatus
|
gptkb:Genentech,_Inc.
active
|
|
gptkbp:hasPartnershipsWith
|
significant
|
|
gptkbp:hasPatentNumber
|
6,789,032
|
|
gptkbp:hasPriorityDate
|
2024-02-06
2003-02-06
|
|
gptkbp:hasPublications
|
2004-09-14
|
|
gptkbp:hasRelatedPatent
|
incremental
US_6,789,031_C16
|
|
gptkbp:hasResearchInterest
|
high
drug development
genetic engineering
|
|
gptkbp:hasTechnicalField
|
molecular biology
|
|
gptkbp:hasTechnology
|
Describes a novel method.
Involves genetic engineering.
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,032 C16
|
|
gptkbp:isAssignedTo
|
gptkb:Genentech,_Inc.
|
|
gptkbp:isCitedBy
|
gptkb:US_11,111,111_B2
gptkb:US_12,345,678_B2
gptkb:US_7,123,456_B2
gptkb:US_7,654,321_B1
gptkb:US_8,765,432_B1
gptkb:US_9,876,543_B2
US_10,000,000_B2
|
|
gptkbp:isExaminedBy
|
gptkb:USPTO
|
|
gptkbp:isFiledIn
|
gptkb:California
gptkb:United_States
|
|
gptkbp:isFiledUnder
|
intellectual property
patent law
utility patent
|
|
gptkbp:isGranted
|
true
|
|
gptkbp:isPartOf
|
patent litigation
biopharmaceutical industry
patent portfolio
US_patent_system
|
|
gptkbp:isPublishedIn
|
USPTO database
|
|
gptkbp:isRelatedTo
|
therapeutic proteins
therapeutic applications
recombinant DNA technology
biopharmaceutical research
protein expression systems
C16 protein
|
|
gptkbp:market
|
high
|
|
gptkbp:relatedTo
|
biotechnology
|
|
gptkbp:usesTechnology
|
CRISPR technology
|